Literature DB >> 12220503

The identification of thymidylate synthase peptide domains located in the interface region that bind thymidylate synthase mRNA.

Donna M Voeller1, Maria Zajac-Kaye, Robert J Fisher, Carmen J Allegra.   

Abstract

Thymidylate synthase (TS) is a critical chemotherapeutic target and intracellular levels of TS are an important determinant of sensitivity to TS inhibitors. Translational autoregulation represents one cellular mechanism for controlling the level of expression of TS. This mechanism involves the binding of TS protein to its own messenger RNA (mRNA), thus, repressing translational efficiency. The presence of excess substrate or inhibitors of TS leads to derepression of protein binding to mRNA, resulting in increased translational efficiency and ultimately increased levels of TS protein. TS protein has been shown to bind to two distinct areas on its mRNA. The goal of the present work is to define the TS domains responsible for this interaction. Using a separate series of overlapping 17-mer peptides spanning the length of both the human and Escherichia coli TS sequences, we have identified six potential domains located in the interface region of the TS protein that bind TS mRNA. The identified domains that bind TS mRNA include three concordant regions in both the human and E. coli peptide series. Five of the six binding peptides contain at least one invariant arginine residue, which has been shown to be critical in other well-defined protein-RNA interactions. These data suggest that the identified highly conserved protein domains, which occur at the homodimeric interface of TS, represent potential participating sites for binding of TS protein to its mRNA.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12220503     DOI: 10.1016/s0006-291x(02)02080-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Binding and repression of translation of the cognate mRNA by Trichinella spiralis thymidylate synthase differ from the corresponding interactions of the human enzyme.

Authors:  Joanna Cieśla; Elzbieta Jagielska; Tomasz Skopiński; Magdalena D Abrowska; Frank Maley; Wojciech Rode
Journal:  Biochem J       Date:  2005-09-15       Impact factor: 3.857

2.  Protein-protein interface-binding peptides inhibit the cancer therapy target human thymidylate synthase.

Authors:  Daniela Cardinale; Giambattista Guaitoli; Donatella Tondi; Rosaria Luciani; Stefan Henrich; Outi M H Salo-Ahen; Stefania Ferrari; Gaetano Marverti; Davide Guerrieri; Alessio Ligabue; Chiara Frassineti; Cecilia Pozzi; Stefano Mangani; Dimitrios Fessas; Remo Guerrini; Glauco Ponterini; Rebecca C Wade; M Paola Costi
Journal:  Proc Natl Acad Sci U S A       Date:  2011-07-27       Impact factor: 11.205

3.  Hotspots in an obligate homodimeric anticancer target. Structural and functional effects of interfacial mutations in human thymidylate synthase.

Authors:  Outi M H Salo-Ahen; Anna Tochowicz; Cecilia Pozzi; Daniela Cardinale; Stefania Ferrari; Yap Boum; Stefano Mangani; Robert M Stroud; Puneet Saxena; Hannu Myllykallio; Maria Paola Costi; Glauco Ponterini; Rebecca C Wade
Journal:  J Med Chem       Date:  2015-04-01       Impact factor: 7.446

4.  New Insight into the Octamer of TYMS Stabilized by Intermolecular Cys43-Disulfide.

Authors:  Dan Xie; Lulu Wang; Qi Xiao; Xiaoyan Wu; Lin Zhang; Qingkai Yang; Lina Wang
Journal:  Int J Mol Sci       Date:  2018-05-07       Impact factor: 5.923

5.  Evidence of Destabilization of the Human Thymidylate Synthase (hTS) Dimeric Structure Induced by the Interface Mutation Q62R.

Authors:  Cecilia Pozzi; Ludovica Lopresti; Matteo Santucci; Maria Paola Costi; Stefano Mangani
Journal:  Biomolecules       Date:  2019-04-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.